JUMPCAN(SH:600566) Xin Lang Cai Jing·2025-11-07 05:25Core Points - Jichuan Pharmaceutical experienced a 5.38% increase in stock price, reaching 26.65 CNY per share, with a trading volume of 298 million CNY and a turnover rate of 1.25%, resulting in a total market capitalization of 24.536 billion CNY [1] - The company, established on January 22, 1997, and listed on August 22, 2001, is primarily engaged in the research, production, and sales of pharmaceuticals, with revenue composition of 77.82% from traditional Chinese medicine, 19.27% from Western medicine, and 2.66% from other sources [1] Shareholder Analysis - Among the top circulating shareholders of Jichuan Pharmaceutical, a fund under Southern Fund holds a significant position. The Southern CSI 500 ETF (510500) reduced its holdings by 106,800 shares in the third quarter, now holding 5.375 million shares, which accounts for 0.59% of circulating shares [2] - The Southern CSI 500 ETF has a current scale of 140.098 billion CNY and has achieved a year-to-date return of 30.24%, ranking 1822 out of 4216 in its category, with a one-year return of 21.69%, ranking 2045 out of 3913 [2] - The fund manager, Luo Wenjie, has been in position for 12 years and 203 days, overseeing a total fund asset size of 170.445 billion CNY, with the best return during his tenure being 152.02% and the worst being -47.6% [2]